Lunai Bioworks Inc
Lunai Bioworks Inc (LNAI) Covered Calls
No qualifying covered call setups were found for LNAI in the prior session.
Read more
Running LNAI covered calls helps you generate consistent income from Lunai Bioworks Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Lunai Bioworks Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best LNAI covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if LNAI stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling LNAI covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Lunai Bioworks Inc covered call is worth writing.
A company rebranding from Renovaro, focusing on AI-powered therapeutics and biodefense, with “Neurotoxicity Intelligence Technology” in development.
Income-focused investors, long-term LNAI holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling LNAI covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Lunai Bioworks Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile—
- Market cap (M$)11
- 52 weeks high-93.56%
- 52 weeks low93.33%
- Analyst recommendation—
- Target price—
- Dividend—
- Payout ratio—
- Earnings date—
- P/E—
- Future P/E—
- EPS (ttm)-7.66
- EPS growth next 5 years—
As of October 23, 2026
No illustrative rows to display.
As of October 23, 2026
Sell covered calls with the data behind you
Find the best LNAI covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→